Invesco PHLX Semiconductor ETF (NASDAQ: SOXQ)

에 대한 최신 뉴스 Invesco PHLX Semiconductor ETF (NASDAQ:SOXQ)

Technology

The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq, Inc. (Nasdaq or the Index Provider) compiles the Underlying Index, which is a modified market-capitalization weighted index designed to measure the performance of the 30 largest companies listed in the United States that are engaged in the semiconductor business, as determined by the Index Provider.

Nvidia Corp.

Broadcom Inc

Advanced Micro Devices Inc.

Texas Instruments Inc

Taiwan Semiconductor - Adr

Kla Corp.

Intel Corp.

Analog Devices, Inc.

Nxp Semiconductors Nv

Lam Research Corp

Invesco PHLX Semiconductor ETF

Equities

Large Cap

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Tech

ETFs

AAPL

ACLS

AVGO

MSFT

NVDA

NVMI

OLED

QRVO

SOXQ

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

인공 지능의 추진에 힘입어 반도체 기업들의 주가가 고공행진을 이어가고 있는 가운데, 현재 미국 칩 제조 산업은 총 가치가 6조 3천억 달러에 달한다. Invesco PHLX 반도체 ETF(NYSE:SOXQ)가 반영하는 필라델피아 반도체 지수(PHLX Semiconductor Sector Index)는 이번 주에 6% 상승할 것으로 예상되어 두 달 만에 가장 강력한 실적을 기록하고 사상 최고 수준을 달성했다.

반도체 업계가 $6조 3천억에 도달, 사상 최고 기록: 이번 주 엔비디아를 앞선 5개의 칩 주식

News

Price Target

Reiteration

Analyst Ratings

Trading Ideas

Piper Sandler의 애널리스트 Harsh V. Kumar은 Advanced Micro Devices, Inc(NASDAQ:AMD)에 대해 195달러의 목표 주가로 Overweight 평가를 재확인했습니다.



분석가는 올해에 AMD에 대한 기대와 특히 MI300 램프 제품의 전망 및 서버 사업에 대한 의견을 업데이트 하였습니다. 



MI300의 가격 대 성능 비율이 매우 강하고

AMD의 MI300 칩은 힘을 얻으며, 분석가들은 강력한 성장과 서버 시장에서의 성공을 전망

Rezolve AI's Brain Suite To Be Distributed Via Microsoft Azure Marketplace With Go-To-Market And Co-Sell Support; Partnership Aims To Deliver Advanced Digital Engagement Capabilities For Retailers

RZLV

Microsoft And Rezolve AI Announce Strategic Partnership To Drive Global Retail Innovation With AI-Powered Commerce Solutions

flight inventory through Sabre's global network of travel buyers.
SOUTHLAKE, Texas, Oct. 3, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4269591-1&amp;h=2300094481&amp;u=http%3A%2F%2Fwww.sabre.com%2F&amp;a=Sabre+Corporation">Sabre Corporation</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABR#NASDAQ">SABR</a>), a leading provider of software and technology that powers the global travel industry, announced today a multi-year distribution agreement with the Dominican flag carrier Arajet.
Under the agreement, Arajet will distribute its inventory of flights, offers and services through a vast network of travel agents across the world, giving Sabre-connected agents access to additional airline content to create personalized offers and experiences for their leisure travelers through the Sabre <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4269591-1&amp;h=3051953627&amp;u=https%3A%2F%2Fwww.sabre.com%2Ftransforming-global-distribution-system%2F&amp;a=Global+Distribution+System+(GDS)">Global Distribution System (GDS)</a>.

SABR

Sabre And Arajet Sign Multi-Year Distribution Agreement To Expand Reach And Boost Sales, Allowing The Airline To Strengthen The Distribution Of Its Flight Inventory Through Sabre's Global Network Of Travel Buyers.

BMO Capital analyst Rufus Hone maintains Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) with a Outperform and raises the price target from $350 to $390.

CPAY

BMO Capital Maintains Outperform on Corpay, Raises Price Target to $390

Macro Economic Events

Econ #s

Economics

USA Initial Jobless Claims 225K Vs 222k Est.; 219K Prior

USA Continuing Jobless Claims 1,826K Vs 1,834K Prior (Revised To 1,827K)

BMO Capital analyst Rufus Hone maintains Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) with a Outperform and lowers the price target from $93 to $92.

BMO Capital Maintains Outperform on Block, Lowers Price Target to $92

BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) with a Buy and raises the price target from $15 to $20.

BTSG

BTIG Maintains Buy on BrightSpring Health, Raises Price Target to $20

BMO Capital analyst Rufus Hone maintains PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) with a Market Perform and raises the price target from $72 to $73.

PYPL

BMO Capital Maintains Market Perform on PayPal Holdings, Raises Price Target to $73

When Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) announced plans to acquire Frontier Communications Parent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FYBR#NASDAQ">FYBR</a>) in <a href="https://www.benzinga.com/markets/equities/24/09/40727235/verizon-to-acquire-frontier-in-20b-deal-reaffirms-fy24-outlook">September for $20 billion</a>, some investors were likely eyeing potential gains from the company's dividends. 
As of now, Verizon offers an annual dividend yield of 6.02%. That&#8217;s a quarterly dividend of 67.75 cents per share ($2.71 a year).
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $99,741 or around 2,214 shares. For a more modest $100 per month or $1,200 per year, you would need $19,957 or around 443 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($2.71 in this case). So, $6,000 / $2.71 = 2,214 ($500 per month), and $1,200 / $2.71 = 443 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
Price Action: Shares of Verizon fell 0.4% to close at $45.05 on Wednesday.
On Oct. 1, Tigress Financial analyst Ivan Feinseth maintained Verizon with a Buy rating and raised the price target from $52 to $55.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41156151/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Image: Shutterstock

Earnings

Long Ideas

Markets

FYBR

How To Earn $500 A Month From Verizon Stock

BMO Capital analyst Rufus Hone maintains Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) with a Outperform and raises the price target from $300 to $310.

BMO Capital Maintains Outperform on Visa, Raises Price Target to $310

Jim Cramer has urged companies to reduce prices to attract consumers amid ongoing inflation concerns. He emphasized the need for a &#8220;giant reset&#8221; in pricing strategies.
What Happened: Cramer pointed out that while price increases have slowed, many businesses are hesitant to lower them due to worries about gross margins. He believes this reluctance is misguided and that companies must recognize the necessity for price reductions, CNBC <a href="https://www.cnbc.com/2024/10/02/cramer-says-companies-must-lower-prices-time-for-a-giant-reset.html">reported</a> on Wednesday.
"Companies are so reluctant to take prices down because they don't want to hurt their treasured gross margins," he said.
"But I think it may be time for a giant reset."
He cited examples, such as liquor companies attributing declining sales to changing consumer preferences rather than high costs. Cramer also mentioned Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), which reported a mixed quarter, as an example of how inflation is affecting business.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41134194/odds-of-tim-walz-winning-the-vp-debate-drop-on-polymarket-as-bettors-favor-jd-vance-harris?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Odds Of Tim Walz Winning The VP Debate Drop On Polymarket As Bettors Favor JD Vance — Harris Maintains Lead Over Trump</a>
Cramer noted that consumers and Wall Street are favoring companies offering lower prices. He mentioned McDonald&#8217;s Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) extending its $5 value meal and noted stock gains for Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Costco Wholesale Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), and Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) as evidence.
Cramer predicted that 2024 will be remembered as the year consumers rejected inflated prices, leading to significant consequences for companies that fail to adjust.
Why It Matters: The call for price reductions comes at a time when market sentiment remains cautious. Traders are in a <a href="https://www.benzinga.com/news/earnings/24/10/41161081/us-stocks-staring-at-another-weak-open-as-traders-await-key-jobs-report-sentiment-wavers-as-oil-ext">&#8220;wait-and-watch&#8221; mode</a>, anticipating key economic data, including non-farm payrolls. This cautious sentiment is compounded by geopolitical tensions and other economic factors.
Additionally, the S&amp;P 500 recently <a href="https://www.benzinga.com/markets/equities/24/09/41029448/s-p-500-hits-all-time-highs-nasdaq-100-tops-20k-ahead-of-key-economic-data-whats-driving-markets">reached record highs</a>, with the Nasdaq 100 surpassing the 20,000-point mark. Despite these gains, the market has shown sideways performance as investors digest positive stimulus news from China and await further economic data. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/commodities/24/10/41151338/biden-the-master-oil-trader-part-iv-president-loads-up-on-millions-of-barrels-to-refill-emerg?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Biden The Master Oil Trader Part IV? President Loads Up On Millions Of Barrels To Refill Emergency Stash In &#8216;One Of The Best Oil Trades In History&#8217;</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Analyst Color

General

AMZN

COST

Jim Cramer Pushes For Strategic Price Cuts Among Companies Amid Inflation Worries: 'It May Be Time For A Giant Reset'

Over two hundred pregnant women faced criminal charges for conduct related to pregnancy, abortion, pregnancy loss or birth during the first year following the Dobbs v. Jackson Women's Health Organization decision. Some women faced prosecution for using medical marijuana, despite being registered patients under state law, as <a href="https://www.marijuanamoment.net/hundreds-of-women-are-being-prosecuted-for-using-marijuana-or-other-drugs-while-pregnant-following-roes-repeal-report-shows/">highlighted</a> by Marijuana Moment's Ben Adlin.
That's according to a report from Pregnancy Justice, a reproductive rights organization, titled "Pregnancy as a Crime: A Preliminary Report on the First Year After Dobbs."
Following the landmark decision of the U.S. Supreme Court to overrule Roe v. Wade and Planned Parenthood v. Casey, eliminating the constitutional right to abortion 2022, dated June 24, 2022, a sharp increase in pregnancy-related prosecutions is evident.
The <a href="https://www.pregnancyjusticeus.org/press/new-pregnancy-justice-report-shows-high-number-of-pregnancy-related-prosecutions-in-the-year-after-dobbs/">report</a> found that "in the one year from June 24, 2022, to June 23, 2023, there was the highest number of pregnancy-related prosecutions documented in&nbsp;a&nbsp;single year."&nbsp;
Nearly 97% of 210 criminal cases filed cited substance use during pregnancy.
In 133 of those cases, drug use was the only allegation made. Following methamphetamines, cannabis was the second most common drug appearing in 86 of the total number of cases.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/02152323/ccc-oct-24-banner__1_-3.gif" alt="" class="wp-image-577305" /></a></figure>
"It is significant that, in eighty-six cases, the police or prosecution alleged that the defendant took some form of THC during her pregnancy, and in thirty-one of those eighty-six cases, the only allegation supporting prosecution was THC use," the report said. "Even more startling, in five of those cases, the court file included statements that the defendant had a medical marijuana card, indicating that she was being charged with taking legally prescribed medication."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/05/32553682/canadian-study-raises-alarm-about-cannabis-use-during-pregnancy-as-er-and-hospital-visits-increa">Canadian Study Raises Alarm About Cannabis Use During Pregnancy As ER And Hospital Visits Increase</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Research On Cannabis And Pregnancy</h3>
Meanwhile, the growing body of research shows opposing results when it comes to cannabis use in pregnancy.
A recent <a href="https://www.ajog.org/article/S0002-9378(24)00682-3/abstract">study</a> from the Hebrew University in collaboration with the Hadassah Medical Center examined the potential long-term risks of prenatal cannabis use on children's neurological development. <a href="https://www.benzinga.com/markets/cannabis/24/09/41005364/using-weed-while-pregnant-study-of-500k-people-reveals-surprising-findings-some-better-than-othe">The research</a> which included more than 500,000 participants, found that THC, a molecule found in cannabis, can cross the placenta and potentially influence the developing fetal brain. The connection between marijuana use during pregnancy and autism, schizophrenia or depression was not confirmed by researchers.
Separately, a study <a href="https://www.nature.com/articles/s44220-024-00281-7">published</a> in the journal Nature Mental Health (via Health Day News) on July 4, 2024, reveals that children exposed to cannabis in utero exhibit brain patterns indicative of reduced inflammation, which could hinder critical developmental processes. The study, led by David Baranger, a postdoctoral fellow at Washington University in St. Louis, did find that prenatal cannabis exposure might influence the developing brain in ways <a href="https://www.benzinga.com/markets/cannabis/24/07/39742388/cannabis-use-during-pregnancy-linked-to-child-brain-development-changes-study-finds">associated with mental health.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39860975/prenatal-cannabis-exposure-not-linked-to-elevated-risk-of-autism-and-oklahoma-court-rules-pregna">Prenatal Cannabis Exposure Not Linked To Elevated Risk Of Autism And Oklahoma Court Rules Pregnant Moms Who Use It Are Not Breaking The Law</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/07/33271933/cannabis-during-pregnancy-no-impact-on-child-neurodevelopment-suggests-new-study">Cannabis During Pregnancy: No Impact On Child Neurodevelopment, Suggests New Study</a></li>
</ul>

Cannabis

Health Care

Women Face Criminal Charges Over Pregnancy For Medical Cannabis Use, Record Number Of Prosecutions In Year After Dobbs

SCYNEXIS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCYX#NASDAQ">SCYX</a>), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced upcoming presentations of preclinical efficacy and pharmacokinetic data on its second-generation fungerp candidate SCY-247 at IDWeek 2024 taking place in Los Angeles, CA from October 16-19, 2024. &nbsp;
Presentation details can be found below:
Oral Presentation:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Title:</td>
<td>Efficacy of SCY-247, a Second-generation Triterpenoid Antifungal, in Three Murine Models of Invasive Fungal Infections</td>
</tr>
<tr>
<td>Session:</td>
<td>Mycology Matters: Insights into Fungal Infections</td>
</tr>
<tr>
<td>Date/Time:</td>
<td>Thursday October 17, 2024 at 10:45 AM PDT</td>
</tr>
<tr>
<td>Location:</td>
<td>Los Angeles Convention Center, Room 403 B</td>
</tr>
<tr>
<td>Presenting author:</td>
<td>David A. Angulo, M.D., President and CEO of SCYNEXIS</td>
</tr>
</tbody>
</table>
</figure>
 Poster Presentation:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Title:</td>
<td>SCY-247: A Second-generation IV/Oral Triterpenoid Antifungal with Extensive Tissue Distribution and Pharmacokinetics, and Low Drug-Drug Interaction Potential</td>
</tr>
<tr>
<td>Session:</td>
<td>New Drug Development</td>
</tr>
<tr>
<td>Date/Time:</td>
<td>Friday October 18, 2024 at 12:15 – 1:30 PM PDT</td>
</tr>
<tr>
<td>Location:</td>
<td>Los Angeles Convention Center, Halls JK</td>
</tr>
<tr>
<td>Presenting author:</td>
<td>David A. Angulo, M.D., President and CEO of SCYNEXIS</td>
</tr>
</tbody>
</table>
</figure>
 For more information, see the IDWeek website <a href="https://www.globenewswire.com/Tracker?data=6hJ60YVzqYkIPXldH-wotp4NTWYc83wNsK-9McWX8cfhFSI8ij-8-icJ86IP903N">here</a>.

Biotech

SCYX

SCYNEXIS To Present Preclinical Data On Second Generation Fungerp SCY-247 At IDWeek 2024

Farmland Partners Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FPI#NYSE">FPI</a>) shares are trading lower on Thursday.
The company said it is selling a portfolio of 46 farms, comprising 41,554 acres of farmland, for $289 million in a single <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41155389/farmland-partners-to-sell-289-million-of-farmland-to-farmland-reserve-inc" rel="noreferrer noopener">transaction with Farmland Reserve.</a>
The portfolio includes farms across several regions and states, including Arkansas, Florida, Louisiana, Mississippi, Nebraska, Oklahoma, and the Carolinas.&nbsp;
&#8220;Farmland is a &#8216;total return&#8217; investment, with asset appreciation typically accounting for a majority of the overall return on invested capital,&#8221; said Luca Fabbri, FPI&#8217;s President and CEO.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41158551/tim-cook-offloads-over-220k-apple-shares-worth-50m" rel="noreferrer noopener">Tim Cook Offloads Over 220K Apple Shares Worth $50M</a>
The CEO indicated that the firm plans to use the resulting capital to reduce debt by around $140 million, buy back stock, pursue acquisitions, and address other corporate purposes.
Additionally, he noted that similar to the previous year, they expect to be able to make a significant special distribution to shareholders at year-end.
According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>, FPI stock has gained over 2% in the past year. The company had a total debt outstanding of approximately <a href="https://www.benzinga.com/pressreleases/24/07/b39942070/farmland-partners-inc-reports-second-quarter-2024-results" target="_blank" rel="noreferrer noopener">$393.0 million on June 30, 2024.</a>
As of June 30, the company had access to liquidity of $163.8 million, consisting of $5.7 million in cash and $158.1 million in undrawn availability under its credit facilities compared to cash of $5.5 million and $201.1 million in undrawn availability under its credit facilities at December 31, 2023.
Following the latest development, the company&#8217;s total gain on sale will be approximately $50 million, or approximately 21% over the aggregate net book value of the farms comprising the portfolio.
In 2023, FPI also sold approximately $200 million of assets at a gain in excess of 20%.
Price Action: FPI shares are trading lower by 1.04% to $10.20 premarket at last check Thursday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41087674/openais-searchgpt-set-to-disrupt-googles-search-empire-as-former-engineer-sounds-alarm-on-deteriorat?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">OpenAI&#8217;s SearchGPT Set To Disrupt Google&#8217;s Search Empire As Former Engineer Sounds Alarm On Deteriorating User Experience Amid Rising Competition</a></li>
</ul>

Asset Sales

Movers

First Trust Advantage Preferred Income Fund

Farmland Partners Sells 46-Farm Portfolio For $289M: Details

Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) ("Gorilla" or the "Company"), today issued a firm statement regarding its uncompromising approach to safeguarding the integrity of its stock. The Company has been relentless in policing trading activities around its securities and is deeply concerned by what it sees as ongoing manipulation attempts.
In August 2023, Gorilla announced that an investigation of suspicious trading activity had uncovered evidence suggesting manipulation of its share price. In June and again in September this year, Gorilla identified further suspicious trading activity. This suspected manipulation was promptly and thoroughly investigated, and the findings have been reported to the U.S. Securities and Exchange Commission (SEC). The Company will not tolerate any actions that undermine the transparency and fairness of the market and Gorilla will continue to actively monitor and combat any such behaviour to protect our shareholders.
We would also like to reaffirm that Gorilla will seek additional opportunities to repurchase more of its shares under its recently announced share buyback programme, reaffirming our belief that the company's stock remains substantially undervalued given the Company's announced financial performance. The Company is focused on continuing to execute on its business strategy and deliver continued growth and profitability.

Short Sellers

Buybacks

GRRR

Gorilla Technology Takes Stance Against Market Manipulation; Reaffirms That It Will Seek Additional Opportunities To Repurchase More Of Its Shares Under Its Recently Announced Share Buyback Program

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Morgan Stanley raised the price target for Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) from $5 to $6. Morgan Stanley analyst Daniel Kutz maintained an Equal-Weight rating. Transocean shares fell 1.4% to close at $4.33 on Wednesday. <a href="https://www.benzinga.com/quote/RIG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho lowered the price target for Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) from $17 to $8. Mizuho analyst Vijay Rakesh downgraded the stock from Neutral to Underperform. Wolfspeed shares gained 2.9% to close at $9.15 on Wednesday. <a href="https://www.benzinga.com/quote/WOLF/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group slashed Academy Sports and Outdoors, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) price target from $65 to $60. Evercore ISI Group analyst Greg Melich downgraded the stock from Outperform to In-Line. Academy Sports and Outdoors shares fell 1.3% to close at $55.56 on Wednesday. <a href="https://www.benzinga.com/quote/ASO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank raised Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) price target from $600 to $620. Deutsche Bank analyst Scott Deuschle maintained a Buy rating. Lockheed Martin shares fell 0.4% to close at $603.20 on Wednesday. <a href="https://www.benzinga.com/quote/LMT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank slashed The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) price target from $225 to $195. Deutsche Bank analyst Scott Deuschle maintained a Buy rating. Boeing shares fell 0.9% to close at $152.89 on Wednesday. <a href="https://www.benzinga.com/quote/BA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised the price target for CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) from $177 to $180. B of A Securities analyst Craig Siegenthaler maintained an Underperform rating. CME fell 0.8% to close at $223.57 on Wednesday. <a href="https://www.benzinga.com/quote/CME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank raised GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) price target from $212 to $235. Deutsche Bank analyst Scott Deuschle maintained a Buy rating. GE Aerospace shares gained 0.1% to close at $186.44 on Wednesday. <a href="https://www.benzinga.com/quote/GE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler raised the price target for On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) from $52 to $56. Piper Sandler analyst Anna Andreeva maintained an Overweight rating. On Holding shares fell 0.3% to close at $49.21 on Wednesday. <a href="https://www.benzinga.com/quote/ONON/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities cut CoreCard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCRD#NYSE">CCRD</a>) price target from $19 to $15. B. Riley Securities analyst Hal Goetsch downgraded the rating from Buy to Neutral. CoreCard shares fell 4.6% to close at $13.89 on Wednesday. <a href="https://www.benzinga.com/quote/CCRD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) price target from $35 to $15. Morgan Stanley analyst Devin McDermott downgraded the stock from Overweight to Equal-Weight. New Fortress Energy shares fell 7.6% to close at $8.94 on Wednesday. <a href="https://www.benzinga.com/quote/NFE/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying GE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="512" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13-1024x512.png" alt="" class="wp-image-578508" style="width:618px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03081857/image-13.png 1342w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41156151/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

Pre-Market Outlook

CCRD

ONON

WOLF

GE Aerospace To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday

Critical Infrastructure, Commercial Fleets and Family Law Highlight New Global Applications
DENVER, CO / ACCESSWIRE / October 3, 2024 / <a href="https://pr.report/93sDhZjn">SOBR Safe, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) ("SOBRsafe"), provider of next-generation transdermal alcohol detection solutions, today provided an update on the opportunity for international expansion across three foundational markets. In each case below, SOBRsafe was approached by the interested party to engage our technologies.

Global

SOBR

SOBRsafe Provides International Update On The Opportunity For International Expansion Across Three Foundational Markets, India, Italy and Australia

Partnership Features Opportunities for Future Expansion;
Announcement Arrives Alongside Clout's New Marketplace and Revitalized Platform Offerings
FRISCO, TX / ACCESSWIRE / October 3, 2024 / Zoned, a full-service marketing agency dedicated to bridging the gap between gaming and pop culture, and wholly owned subsidiary of GameSquare Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) ("GameSquare", or the "Company"), today announced a new partnership with Clout, a platform for esports enthusiasts. The expansive partnership includes a six-figure retainer deal, with opportunities for future expansion and renewal. Today's announcement arrives alongside the launch of Clout's revitalized platform offerings and new best-in-class features.
Clout is a cutting-edge platform designed for esports fans to participate in free-to-play contests, earn XP, and receive exclusive rewards on its Marketplace. Through Clout, users can predict team and player outcomes, play friendly pick'ems and minigames, track their results in real-time, and redeem unique prizes. The partnership between Zoned and Clout aims to further enhance user engagement and introduce new gamified experiences for the esports community.

Contracts

GAME

GameSquare's Zoned Announces Six-Figure Retainer Deal With Clout To Gamify Watching Esports

BTIG analyst David Larsen maintains Astrana Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTH#NASDAQ">ASTH</a>) with a Buy and raises the price target from $60 to $70.

ASTH

BTIG Maintains Buy on Astrana Health, Raises Price Target to $70

Northland Capital Markets analyst Carl Byrnes maintains BrainsWay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWAY#NASDAQ">BWAY</a>) with a Outperform and raises the price target from $11 to $12.5.

BWAY

Northland Capital Markets Maintains Outperform on BrainsWay, Raises Price Target to $12.5

A Cruel Inflation Summer - BlackRock's Version

Serving Up Volatility: How U.S. Presidential Elections Rally The Securities Lending Markets

Tech And AI Investing Trends: A Stock Picker's Take

How To Invest In AI Vs. Tech In A Portfolio

U.S. Equity Market Betas - Why They Matter And How They Are Changing

Invesco PHLX Semiconductor ETF declares quarterly distribution of $0.06809

SMH: The AI Buildout Is Broadening Out

The Tailwinds Of September

China Goes Big And Fuels More Stock Market Gains; The S&P 500 Has Only Done This 7 Times Before

Comments

Invesco PHLX Semiconductor ETF

뉴스

에 대한 최신 뉴스 Invesco PHLX Semiconductor ETF (NASDAQ:SOXQ)

금요일, 6월 14, 2024

토요일, 4월 06, 2024

뉴스

파트너 / 기고자

벤징가 글로벌